Cancer Biology

847 Eradication of spontaneous malignancy by local immunotherapy.

846 Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.

845 Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells.

844 Detection and localization of surgically resectable cancers with a multi-analyte blood test.

843 Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus.

842 Rapid drug screen using 3D tumor organoids.

841 Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

840 Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.

839 The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients.

838 Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients.

837 Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors.

836 Senescence-associated reprogramming promotes cancer stemness.

835 Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.

834 PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs.

833 The same bacteria present in primary tumors of patients with colorectal cancer are also present in liver metastases.

832 Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.

831 Contemporary Hormonal Contraception and the Risk of Breast Cancer.

830 Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.

829 NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.

828 Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib.

Free Images for Presentation: sunipix SUNIPIX